Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]

Clin Pharmacol. 2020 Dec 9:12:189-190. doi: 10.2147/CPAA.S289793. eCollection 2020.

Authors

Michael Z Liao¹, Johannes Kast¹, Marloes Berkhout², Hans Prenen³, Sandeep Dutta⁴, Vijay V Upreti¹

Affiliations

¹ Clinical Pharmacology, Modeling & Simulation, Amgen Inc., South San Francisco, CA, USA.
² Amgen B.V., Breda, the Netherlands.
³ Antwerp University Hospital, Edegem, Belgium.
⁴ Clinical Pharmacology, Modeling & Simulation, Amgen Inc., Thousand Oaks, CA, USA.

No abstract available

Publication types

Comment